{"id":7020,"date":"2023-11-29T08:30:00","date_gmt":"2023-11-29T07:30:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/"},"modified":"2023-11-29T08:30:00","modified_gmt":"2023-11-29T07:30:00","slug":"nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/","title":{"rendered":"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag"},"content":{"rendered":"
\n

Nanexa AB (publ) meddelar idag att bolaget har tecknat ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement med ett av de st\u00f6rsta globala l\u00e4kemedelbolagen, f\u00f6r utv\u00e4rdering av Nanexas drug delivery-system, PharmaShell\u00ae, i en dep\u00e5formulering av en monoklonal anitikropp.<\/strong><\/p>\n<\/div>\n

\n

Studien avser att skapa en l\u00e5ngtidsverkande formulering av en av l\u00e4kemedelsbolagets monoklonala antikroppar med hj\u00e4lp av PharmaShell-systemet.<\/p>\n

\u201dDet \u00e4r v\u00e4ldigt gl\u00e4djande att addera detta projekt till v\u00e5r portf\u00f6lj av partnersamarbeten och att vi i h\u00e4r nyttjar v\u00e5rt PharmaShell-system inom omr\u00e5det monoklonala anitkroppar som vi bed\u00f6mer har mycket stor potential. Det \u00e4r naturligtvis ocks\u00e5 mycket gl\u00e4djande att Nanexa nu inleder ett samarbete med detta stora l\u00e4kemedelsf\u00f6retag och vi ser fram emot att p\u00e5b\u00f6rja arbetet inom kort, med m\u00e5let att generera resultat som kan ligga till grund f\u00f6r ett mer omfattande utvecklingsprogram\u201d, s\u00e4ger David Westberg, vd f\u00f6r Nanexa.<\/p>\n

Avtalet reglerar bland annat detaljer kring vad som ska unders\u00f6kas, klarg\u00f6rande kring patentr\u00e4ttigheter och en fastst\u00e4lld ers\u00e4ttning till Nanexa f\u00f6r denna utv\u00e4rdering.<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar injicerbara l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland Novo Nordisk och AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa AB (publ) meddelar idag att bolaget har tecknat ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement med ett av de st\u00f6rsta globala l\u00e4kemedelbolagen, f\u00f6r utv\u00e4rdering av Nanexas drug delivery-system, PharmaShell\u00ae, i en dep\u00e5formulering av en monoklonal anitikropp.<\/p>\n","protected":false},"template":"","class_list":["post-7020","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa AB (publ) meddelar idag att bolaget har tecknat ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement med ett av de st\u00f6rsta globala l\u00e4kemedelbolagen, f\u00f6r utv\u00e4rdering av Nanexas drug delivery-system, PharmaShell\u00ae, i en dep\u00e5formulering av en monoklonal anitikropp.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\\\/\",\"name\":\"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2023-11-29T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag - Nanexa AB","og_description":"Nanexa AB (publ) meddelar idag att bolaget har tecknat ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement med ett av de st\u00f6rsta globala l\u00e4kemedelbolagen, f\u00f6r utv\u00e4rdering av Nanexas drug delivery-system, PharmaShell\u00ae, i en dep\u00e5formulering av en monoklonal anitikropp.","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/","name":"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2023-11-29T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-utvarderingsavtal-med-ett-stort-globalt-lakemedelsbolag-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa tecknar utv\u00e4rderingsavtal med ett stort globalt l\u00e4kemedelsbolag"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/7020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=7020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}